STAT3 speeds up progression of osteoarthritis through NF-κB signaling pathway

Feida Wang1, Zhenye Guo1, Yinpeng Yuan1

  • 1Department of Osteopathy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Insights

Osteoarthritis (OA) is a common elderly disease. Researchers identified key regulators, including transcription factor STAT3, involved in OA development, offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Osteoarthritis (OA) is a prevalent motor system disease in the elderly.
  • OA imposes a significant social and economic burden, necessitating research into its pathogenesis.
  • Improving OA therapeutic effects requires a deeper understanding of disease development.

Purpose of the Study:

  • To construct and analyze regulator-mediated OA dysfunction modules.
  • To identify key regulatory factors and signaling pathways involved in OA progression.
  • To uncover potential therapeutic targets for osteoarthritis.

Main Methods:

  • Differential gene expression analysis
  • Gene co-expression analysis
  • Enrichment analysis to identify functional pathways
  • Identification of pivotal regulators within OA modules

Main Results:

  • 16 OA dysfunction modules comprising 3,239 genes were identified.
  • Module genes are significantly associated with apoptosis and inflammation.
  • Key regulators include 842 ncRNAs and 59 transcription factors, with STAT3 identified as a core factor.

Conclusions:

  • STAT3 acts as a core transcription factor promoting OA via the NF-κB signaling pathway.
  • The study provides novel insights into OA pathogenesis for researchers and drug developers.
  • Identified regulators offer a broader range of candidate targets for future OA research.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K